Following previous positive experience with CITA-RNPT of infected pacemakers, we suggest that CITA-RNPT can be administered prophylactically to patients prior to replacement of CIED, immun-compromised patients, and others.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01770067